StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.01−0.13 (-0.97%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Ascentage Pharma Group International r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was CN¥1.14B, up 20.1% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥1.14B+20.1%
FY2024Dec 31, 2024CN¥947.25M+34.0%
FY2023Dec 31, 2023CN¥706.97M-4.9%
FY2022Dec 31, 2022CN¥743.10M–

More Ascentage Pharma Group International figures

See a number that looks wrong?